AcScapeStress · Cell type-specific effects of HDAC1 on stress vulnerability, hippocampal gene regulation and genome-wide acetylation landscape
FP7 — People (Marie Curie Actions)
- Duration
- 2013-06-17 → 2015-06-16
- EU contribution
- €168,794
- Participants
- 1
- Scheme
- MC-IIF
Lines connect the coordinator with its partners.
Results in brief
Periodic Report Summary 1 - ACSCAPESTRESS (Cell type-specific effects of HDAC1 on stress vulnerability, hippocampal gene regulation and genome-wide acetylation landscape)
Cell type-specific effects of HDAC1 on stress vulnerability, hippocampal gene regulation and genome-wide acetylation landscape The project was based on the observation that stress effects can be alleviated by treatment with broad spectrum histone deacetylase inhibitors (HDACis) and levels of HDACs are deregulated following stress exposure in the rodent model or in post mortem tissue of patients with major depression or bipolar disorder. Specific aim of this research was to systematically investigate the role of a single histone deacetylase in stress vulnerability. To this end, Dr. Jakovcevski used conditional Hdac1 knockout mice with Cre recombinase expression under the control of a neuron specific CamK2a promoter, to obtain Hdac1 deficiency, specifically in neurons, at first. These mice were exposed to a chronic stressor and their stress induced behavior was evaluated using a test battery, probing anxiety and depression-like behaviors, typically affected by stressors. To better understand the behavioral stress reactivity, data was compared to the pre-stress, baseline, behavior. Interestingly, under basal conditions Hdac1 knockout mice, displayed behaviors, indicative of stress vulnerability such as increased locomotion in the unfamiliar environment of an open field and anhedonia. Likewise, when tested for their behavioral stress response, Hdac1 knockout mice were affected stronger than wildtypes. To link these behavioral phenotypes to molecular pathways, Dr. Jakovcevski investigated potential gene expression changes in the hippocampus of Hdac1 knockout mice under basal conditions using a conventional microarray for coding mRNA transcripts. This approach identified only a small number of differentially regulated genes, in line with results in cell culture, demonstrating that Hdac1 mostly affects expression levels of non-coding RNAs. Thus, the fellow has switched to RNAseq to include non-coding transcripts in her analysis. Also, since, major differences in gene expression between wildtype and knockout mice might arise only after stress exposure, Dr. Jakovcevski did now include this condition in the experimental setup. Similar, to determine if gene expression changes are linked to a modified histone acetylation landscape, the fellow initially tested which histone acetylation marks are differently regulated at bulk level using Western blot in wildtype versus knockout mice under basal and stressed conditions. Dr. Jakovcevski identified several histone acetylation marks to be changed through Hdac1 inactivation and by stress exposure. For one of the histone acetylation marks, changed the most by both conditions, the fellow performed ChIPseq experiments on hippocampi from all four groups of mice. This set of data, passed quality controls such as read numbers and rate of duplicates. We are still in the process of finalizing the analysis, but preliminary data look very promising. Finally, Dr. Jakovcevski will compare the RNAseq data with the ChIPseq data to understand how the molecular stress response in wildtype mice is different from Hdac1 knockout mice. Here, it will be interesting if changes in the acetylation landscape correlate straight with changes in gene expression, or if changes to the histone landscape at basal conditions might be predictive for gene expression changes after stress exposure and most importantly, if this relationship will be the same for both genotypes. Most prominent changes/ loci will be further tested for their cell type specificity using sorted neural cells. Required technology has been established by the fellow. Thereafter, Dr. Jakovcevski will rescue the phenotype of Hdac1 knockout mice by re-expression or knockdown of the two or three most regulated genes in the most affected neural cell type. From the scientific point of view this research facilitated knowledge on the role of Hdac1 in stress vulnerability. Moreover, the study will significantly increase the knowledge on the cell type specific interaction between histone acetylation and gene regulation in the brain and during adaption/ maladaption to environmental challenges. Since, Hdac1 is target of many broad spectrum HDACis and we have demonstrated an important role of Hdac1 in the response to stress, this project might help to develop more specific treatment options for stress related disorders on the long run. Perhaps, these options might be already focused on cell type-specific downstream targets of Hdac1. Another important aspect of this project is its potential for increasing public awareness on the importance of environmental factors such as stress exposure, which interact with an organism’s genetics through the interface of epigenetic mechanisms, in the development of stress related disorders. This increased awareness may give rise to preventive actions such as stress reduction programs at the work place. Altogether, indirect long-term effects of the project might help to alleviate the personal tragedy of neuropsychiatric disorders from on an individual perspective and reduce the financial burden caused by these disorders from the perspective of society.
Data: CORDIS, © European Union
Project objective
The discovery that broad spectrum histone deacetylase inhibitors (HDACi) can improve depression-related symptoms in humans and in corresponding mouse models in conjunction with the observation that stressors affect the epigenome by changing histone acetylation opened new avenues to a better understanding of the pathophysiology of stress-related disorders. Finding the essential molecular mechanisms of how single histone deacetylases (HDACs) contribute to or ameliorate stress-related pathologies will improve the efficacy of current antidepressant drugs through increased specificity.Aim of this study is to investigate whether and in which way the specific histone deacetylase (HDAC) 1 has an impact on anxiety and depression-like behaviour in adult mice under baseline, non-stressed and stressed conditions using a neuron and forebrain-specific ""loss-of-function"" mouse model (Hdac1 knockout mice). And, the study aims to determine effects of HDAC1 on gene expression and genome-wide acetylation signatures in the hippocamus to identify how the potential protective or detrimental role of HDAC1 in stress response is mediated. Moreover, it is important to understand if the findings are cell type-specific, since HDAC1 is expressed in neurons and glia. Finally, rescue experiments will test whether the phenotype is reversible, which is important for future therapeutic implications.The fellow has acquired the necessary expertise in Dr. Akbarian´s laboratory at UMASS Medical School (now: Mount Sinai School of Medicine). This includes: working with epigenetic mouse models, performing microarrays and especially chromatin immunoprecipitation (ChIP) specific for histone acetylation in conjunction with library preparation for next generation sequencing.The fellow will transfer this knowledge to the host institution, the Max Planck Institute of Psychiatry, which is renowned for the excellent depression and stress research and therefore the best place to conduct the proposed project.""
Original text from CORDIS.
Participants
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV · MUNCHENCoordinatorGermany
Links
Data: CORDIS, © European Union
